Cargando…
Chiari Type III : Experience of Outcome for 15 Cases
OBJECTIVE: Chiari III malformations are extremely rare hindbrain malformations that are associated with a high early mortality rate, or severe neurologic deficits in the survivors. The treatment is early operative closure and cerebrospinal fluid diversion (CSF) shunting. METHODS: We operated on 15 p...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurosurgical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666243/ https://www.ncbi.nlm.nih.gov/pubmed/36281538 http://dx.doi.org/10.3340/jkns.2021.0234 |
_version_ | 1784831460477239296 |
---|---|
author | Gabr, Mohamed Elmataeshy, Mahmoud Abdullah, Ahmed A. |
author_facet | Gabr, Mohamed Elmataeshy, Mahmoud Abdullah, Ahmed A. |
author_sort | Gabr, Mohamed |
collection | PubMed |
description | OBJECTIVE: Chiari III malformations are extremely rare hindbrain malformations that are associated with a high early mortality rate, or severe neurologic deficits in the survivors. The treatment is early operative closure and cerebrospinal fluid diversion (CSF) shunting. METHODS: We operated on 15 patients by repair and excision between July 2014 till June 2020 and retrospective data collection was done. Only one patient doesn’t need ventriculoperitoneal (VP) shunt and the other 14 patients need a VP shunt. We described stepwise dissection and untethering of the cerebellum from the bony edge to regrowth and herniation of cerebellum again into this potential space and simple dural closure or repair with graft was done. RESULTS: We started with VP in eight patients (53%) and the other seven patients (46.7%) started with excision and then six patients need VP shunt later on because four patients developed CSF leak and two patients developed increased high intracranial tension. Only four patients (26.7%) needed a blood transfusion. CONCLUSION: There are variations in the outcome and not all cases of Chiari malformation III will die and severe developmental delay is not a must. Proper management and repair carry a good prognosis. |
format | Online Article Text |
id | pubmed-9666243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Korean Neurosurgical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-96662432022-11-28 Chiari Type III : Experience of Outcome for 15 Cases Gabr, Mohamed Elmataeshy, Mahmoud Abdullah, Ahmed A. J Korean Neurosurg Soc Clinical Article OBJECTIVE: Chiari III malformations are extremely rare hindbrain malformations that are associated with a high early mortality rate, or severe neurologic deficits in the survivors. The treatment is early operative closure and cerebrospinal fluid diversion (CSF) shunting. METHODS: We operated on 15 patients by repair and excision between July 2014 till June 2020 and retrospective data collection was done. Only one patient doesn’t need ventriculoperitoneal (VP) shunt and the other 14 patients need a VP shunt. We described stepwise dissection and untethering of the cerebellum from the bony edge to regrowth and herniation of cerebellum again into this potential space and simple dural closure or repair with graft was done. RESULTS: We started with VP in eight patients (53%) and the other seven patients (46.7%) started with excision and then six patients need VP shunt later on because four patients developed CSF leak and two patients developed increased high intracranial tension. Only four patients (26.7%) needed a blood transfusion. CONCLUSION: There are variations in the outcome and not all cases of Chiari malformation III will die and severe developmental delay is not a must. Proper management and repair carry a good prognosis. Korean Neurosurgical Society 2022-11 2022-10-25 /pmc/articles/PMC9666243/ /pubmed/36281538 http://dx.doi.org/10.3340/jkns.2021.0234 Text en Copyright © 2022 The Korean Neurosurgical Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Article Gabr, Mohamed Elmataeshy, Mahmoud Abdullah, Ahmed A. Chiari Type III : Experience of Outcome for 15 Cases |
title | Chiari Type III : Experience of Outcome for 15 Cases |
title_full | Chiari Type III : Experience of Outcome for 15 Cases |
title_fullStr | Chiari Type III : Experience of Outcome for 15 Cases |
title_full_unstemmed | Chiari Type III : Experience of Outcome for 15 Cases |
title_short | Chiari Type III : Experience of Outcome for 15 Cases |
title_sort | chiari type iii : experience of outcome for 15 cases |
topic | Clinical Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666243/ https://www.ncbi.nlm.nih.gov/pubmed/36281538 http://dx.doi.org/10.3340/jkns.2021.0234 |
work_keys_str_mv | AT gabrmohamed chiaritypeiiiexperienceofoutcomefor15cases AT elmataeshymahmoud chiaritypeiiiexperienceofoutcomefor15cases AT abdullahahmeda chiaritypeiiiexperienceofoutcomefor15cases |